Denhaerynck K, Schmid-Mohler G, Kiss A, Steiger J, Wüthrich R P, Bock A, De Geest S
Institute of Nursing Science, University of Basel, Switzerland.
Division of Nephrology, University Hospital Zürich, Switzerland ; Centre of Clinical Nursing Science, University Hospital Zürich, Switzerland.
Int J Organ Transplant Med. 2014;5(1):7-14.
Literature review suggests that adherence to immunosuppressive drugs may be lower in recipients of living than of deceased donor kidney grafts, possibly because of profile differences.
To compare the level of immunosuppressive adherence levels between patients with deceased and living (-related; -unrelated) donor grafts in Switzerland.
Using data from two similar cross-sectional studies at two transplant centers in Switzerland, the level of adherence between the two groups was compared. Medication adherence was assessed by self-report or electronic monitoring. Possible explanatory factors included age, beliefs regarding immunosuppressive drugs, depressive symptomatology, pre-emptive transplantation, and the number of transplants received, were also considered. Data were analyzed using logistic regression analysis.
Unadjusted non-adherence odds were 2 to 3 times higher in living-related than deceased donor transplantation (ORs: 2.09-3.05; p<0.05). Adjustment for confounders showed that these differences were associated most with the younger age of living-related subjects and the belief that immunosuppressive drugs are less important for living-related donations.
There is a lower immunosuppressive adherence in recipients of living-related donor kidneys, possibly owing to differences in patient profile (ie, health beliefs regarding their immunosuppressive needs), knowledge of which may enhance adherence if addressed.
文献综述表明,活体供肾移植受者对免疫抑制药物的依从性可能低于尸体供肾移植受者,这可能是由于两者特征不同。
比较瑞士尸体供肾移植受者与活体(亲属活体;非亲属活体)供肾移植受者的免疫抑制依从性水平。
利用瑞士两个移植中心两项类似横断面研究的数据,比较两组的依从性水平。通过自我报告或电子监测评估药物依从性。还考虑了可能的解释因素,包括年龄、对免疫抑制药物的看法、抑郁症状、抢先移植以及接受移植的次数。使用逻辑回归分析对数据进行分析。
未经调整时,亲属活体供肾移植的不依从几率比尸体供肾移植高2至3倍(比值比:2.09 - 3.05;p<0.05)。对混杂因素进行调整后显示,这些差异主要与亲属活体供肾移植受者年龄较小以及认为免疫抑制药物对亲属活体供肾移植不那么重要有关。
亲属活体供肾移植受者的免疫抑制依从性较低,可能是由于患者特征不同(即对免疫抑制需求的健康观念),如果解决这一问题,了解这一点可能会提高依从性。